ZURA Zura Bio Ltd
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1855644 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-43.7%
TTM EPS YoY-70.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-65.4%
ROA-55.2%
ROIC (approx.)-164.3%
Asset turnover—
Leverage & solvency
Liabilities / assets8.7%
Debt / equity0.00x
Current ratio11.29x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.24x
Accruals ratio-42.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $42.08M | $24.40M |
| SG&A expense | $33.16M | $30.79M |
| Operating income | -$75.25M | -$55.19M |
| Pretax income | -$68.65M | -$52.40M |
| Income tax | — | $0 |
| Net income | -$68.65M | -$52.40M |
| EBITDA | -$75.20M | -$55.18M |
| EPS (basic) | -1.06 | -0.60 |
| EPS (diluted) | -1.06 | -0.60 |
| Weighted avg. shares (diluted) | 94.16M | 75.07M |
| Balance sheet | ||
| Cash & equivalents | $109.41M | $176,498 |
| Current assets | $112.31M | $178.74M |
| PP&E, net | $126,000 | $91,000 |
| Total assets | $113.95M | $179.53M |
| Current liabilities | $12.41M | $19.51M |
| Total liabilities | $12.41M | $19.51M |
| Shareholders' equity | $101.54M | $146.81M |
| Shares outstanding | 73.68M | 65.30M |
| Cash flow statement | ||
| Operating cash flow | -$64.81M | -$28.08M |
| Capital expenditure | $113,000 | $75,000 |
| Free cash flow | -$64.93M | -$28.15M |
| Investing cash flow | -$113,000 | -$5.08M |
| Financing cash flow | -$2.16M | $109.84M |
| Depreciation & amortization | $49,000 | $9,000 |
| Stock-based compensation | $12.33M | $16.80M |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.